Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 2.230
+0.060 (2.76%)
Jun 1, 2026, 4:08 PM HKT
Luye Pharma Group Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Luye Pharma Group stock has a consensus rating of "Buy" and an average price target of $3.53. The average 1-year stock price forecast is 58.30% higher than the current stock price, while the lowest is $2.72 (+21.97%) and the highest is $4.34 (+94.62%).
Price Target: $3.53 (+58.30%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 19, 2026.
Analyst Ratings
The average analyst rating for Luye Pharma Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $4.34 | Buy | Maintains | $4.34 | +94.62% | Apr 19, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $4.30 | Buy | Maintains | $4.30 | +92.83% | Apr 13, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.